As expected, the IPO markets in Europe made their strongest showing in several years in 2005 and have even topped the amount of money raised in the U.S., according to figures released today by PricewaterhouseCoopers in London.
Charges of scientific fraud in Korea aren't likely to faze Britain's ambitious stem-cell efforts, as evidenced by plans for a £40 million lab run by the 'father' of Dolly the sheep.
Just as most public research bodies embrace commercialisation as their raison d'etre, the UK Medical Research Council is reversing the trend and taking a company it span out earlier back within its fold.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.